Replies to post #99672 on Biotech Values

[DewDiligence]

FoB factoid: NVS is the worldwide market-share leader in the three main currently marketed FoB’s: hGH, EPO, and G-CSF. Omnitrope, NVS’ branded hGH product, is the first FoB from any company to sell more than $100M per year. (I’m not counting Lovenox as an FoB.) Source: NVS’ 3Q11 CC.